Drug Type Small molecule drug |
Synonyms Pylorid, Ranitidine Bismuth, Ranitidine bismuth citrate (USAN) + [5] |
Target |
Action antagonists |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (13 Sep 1995), |
Regulation- |
Molecular FormulaC19H30BiN4O10S |
InChIKeyKMNPCCNMXHDTHJ-UHFFFAOYSA-N |
CAS Registry128345-62-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05699 | Ranitidine Bismuth Citrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erosive esophagitis | United States | 23 Mar 1998 | |
Gastroesophageal Reflux | United States | 23 Mar 1998 | |
Zollinger-Ellison Syndrome | United States | 23 Mar 1998 | |
Helicobacter Infections | United Kingdom | 23 Sep 1995 | |
Stomach Ulcer | United Kingdom | 18 Sep 1995 | |
Duodenal Ulcer | United Kingdom | 13 Sep 1995 |
Phase 4 | 92 | (Omeprazole) | fkknujyzri(lmbfhnvobj) = mzlhrzybke imxtgueorw (zlwlrmflbx, 72.28) View more | - | 23 May 2016 | ||
(Ranitidine) | fkknujyzri(lmbfhnvobj) = zpkxsdlanz imxtgueorw (zlwlrmflbx, 70.12) View more |